Acasti Pharma Probability of Future Stock Price Finishing Over 2.89

ACSTDelisted Stock  USD 3.37  0.01  0.30%   
Acasti Pharma's future price is the expected price of Acasti Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Acasti Pharma performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
  
Please specify Acasti Pharma's target price for which you would like Acasti Pharma odds to be computed.

Acasti Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acasti Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acasti Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Acasti Pharma is now traded under the symbol GRCE. Please update your portfolios or report it if you believe this is an error. Report It!
Acasti Pharma is not yet fully synchronised with the market data
Acasti Pharma is way too risky over 90 days horizon
Acasti Pharma appears to be risky and price may revert if volatility continues
Acasti Pharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 120 K.
Acasti Pharma currently holds about 38.39 M in cash with (12.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86.
Roughly 38.0% of the company shares are held by company insiders

Acasti Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acasti Stock often depends not only on the future outlook of the current and potential Acasti Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acasti Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding9.5 M
Cash And Short Term Investments23 M

Acasti Pharma Technical Analysis

Acasti Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Acasti Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acasti Pharma. In general, you should focus on analyzing Acasti Stock price patterns and their correlations with different microeconomic environments and drivers.

Acasti Pharma Predictive Forecast Models

Acasti Pharma's time-series forecasting models is one of many Acasti Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acasti Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Acasti Pharma

Checking the ongoing alerts about Acasti Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acasti Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Acasti Pharma is now traded under the symbol GRCE. Please update your portfolios or report it if you believe this is an error. Report It!
Acasti Pharma is not yet fully synchronised with the market data
Acasti Pharma is way too risky over 90 days horizon
Acasti Pharma appears to be risky and price may revert if volatility continues
Acasti Pharma has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 120 K.
Acasti Pharma currently holds about 38.39 M in cash with (12.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86.
Roughly 38.0% of the company shares are held by company insiders
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Consideration for investing in Acasti Stock

If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume